EPISODE · Aug 23, 2023 · 1H
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
from Hematologic Oncology Update
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma.
Embed this episode
NOW PLAYING
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
0:00
1:00:50
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Hematologic Oncology Update?
This episode is 1 hour and 0 minutes long.
When was this Hematologic Oncology Update episode published?
This episode was published on August 23, 2023.
Can I download this Hematologic Oncology Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!